In a new study from MedUni Vienna, researchers found a Transcranial Pulse Stimulation with ultrasound (TPS) technique can be used in various neuropsychiatric brain diseases such as Alzheimer’s and Parkinson’s.
It improves brain function by externally activating still-functioning neurons. It has now been demonstrated that TPS can even reduce brain degeneration in dementia patients.
In neurological diseases such as Alzheimer’s or Parkinson’s disease, brain neurons are constantly being lost, resulting in memory lapses, speech disorders, mood swings and impaired mobility, for example, as well as muscle tremors in the case of Parkinson’s.
Treatment options for neurodegenerative diseases are limited and there is currently no cure.
A technique that at least temporarily reduces the breakdown of neurons was developed in Vienna.
Transcranial Pulse Stimulation with ultrasound (TPS) is a non-invasive technique that penetrates all areas of the brain and stimulates those neurons that can help to regenerate brain functions.
Earlier studies have shown that two to four weeks of treatment with Transcranial Pulse Stimulation can improve the functional networks and cognitive performance of Alzheimer’s patients for up to three months.
In this study, the team found that TPS can slow down the cortical atrophy (brain tissue loss) that is typical in Alzheimer’s.
They found a big link between neuropsychological improvement and thickness of the cerebral cortex in areas of the brain that are critical in Alzheimer’s.
These results underline the suitability of this technique as an additional option for treating dementia.
Due to the effectiveness and attractiveness of the practically side-effect-free technique, several TPS treatment and research centers have already been set up in Europe, North America, and Asia.
However, neurological expertise is necessary for low-risk and effective implementation.
If you care about Alzheimer’s, please read studies about these 2 personality traits may protect you from Alzheimer’s disease and more and findings of this new drug may prevent Alzheimer’s disease effectively and safely.
For more information about Alzheimer’s and your health, please see recent studies about your eyes can show early warning for Alzheimer’s disease and results showing a simple tool to predict your risk of Alzheimer’s.
The study is published in Alzheimer’s & Dementia: Translational Research & Clinical Interventions. One author of the study is Roland Beisteiner.
Copyright © 2021 Knowridge Science Report. All rights reserved.